Immediate Impact
66 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Works of C. Rees being referenced
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| C. Rees | 88 | 59 | 42 | 7 | 148 | |
| Nicholas A. Ullman | 126 | 32 | 22 | 10 | 175 | |
| Saad Ullah Akram | 40 | 81 | 27 | 9 | 168 | |
| Ruben I. Calderon | 66 | 79 | 15 | 5 | 142 | |
| Matthew S. Strand | 69 | 65 | 36 | 10 | 156 | |
| Michel Vulfovich | 52 | 52 | 12 | 9 | 123 | |
| Christina M. Covington | 88 | 34 | 19 | 6 | 143 | |
| Hani S. Mousa | 84 | 46 | 19 | 7 | 205 | |
| Stefano Brignola | 103 | 73 | 72 | 8 | 202 | |
| Jiang Lv | 149 | 58 | 39 | 8 | 202 | |
| Mitsuhiro Komura | 91 | 64 | 15 | 9 | 202 |
All Works
Loading papers...